首页> 外文会议>15th World Congress on Breast Disease and 3rd Shanghai Breast Cancer Symposium(第十五届国际乳腺病大会暨第三届上海国际乳腺癌论坛) >A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone
【24h】

A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone

机译:具有高CD44 + CD24- /低表型转移到人骨的人乳腺癌干细胞样小鼠的新型模型

获取原文
获取原文并翻译 | 示例

摘要

Background: At present, our understanding of the development of bone metastasis is limited. Therefore, little progress has been made in preventing skeletal metastasis in the breast cancer patient. A satisfactory animal model that avoids the species-specific factor and simultaneously shares similarities to the clinical pathophysiological progression of breast cancer metastasizing to bone is unavailable. A subpopulation (CD44+/CD24-/lower) of breast cancer cells possesses stem/progenitor cell properties (cancer stem-like cell). CD44 potentiates the adherence of metastatic breast cancer cells to bone marrow endothelial cells. In the present study, we used hepatocyte growth factor to enhance the proportion of CD44+/CD24-/lower subpopulation in the human breast cancer cell line MDA-MB-231. We used these human breast cancer stem-like cells and implantation of human bone to build a novel "human-source" model of human breast cancer skeletal metastasis.
机译:背景:目前,我们对骨转移的发展了解有限。因此,在预防乳腺癌患者的骨骼转移方面进展甚微。无法获得一种令人满意的动物模型,该模型避免了物种特异性因子,同时与转移至骨骼的乳腺癌的临床病理生理进展具有相似性。乳腺癌细胞的亚群(CD44 + / CD24- /下)具有干/祖细胞特性(癌干样细胞)。 CD44增强了转移性乳腺癌细胞对骨髓内皮细胞的粘附。在本研究中,我们使用肝细胞生长因子来提高人乳腺癌细胞系MDA-MB-231中CD44 + / CD24- /低等亚群的比例。我们使用这些人类乳腺癌干细胞样细胞和人类骨骼植入物来构建人类乳腺癌骨骼转移的新型“人类来源”模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号